Cargando…

Advances in the Study of Circadian Genes in Non-Small Cell Lung Cancer

Circadian genes regulate several physiological functions such as circadian rhythm and metabolism and participate in the cytogenesis and progression of various malignancies. The abnormal expression of these genes in non-small cell lung cancer (NSCLC) is closely related to the clinicopathological feat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hao, Liu, Renwang, Zhang, Bo, Huo, Huandong, Song, Zuoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121494/ https://www.ncbi.nlm.nih.gov/pubmed/35575281 http://dx.doi.org/10.1177/15347354221096080

Ejemplares similares

Anterior mediastinal metastasis of primary fallopian tube adenocarcinoma: a case report
por: Zhang, Bo, et al.
Publicado: (2020)

Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study
por: Zhang, Bo, et al.
Publicado: (2021)

Lobectomy versus sublobar resection for stage I (T1‐T2aN0M0) small cell lung cancer: A SEER population‐based propensity score matching analysis
por: Zhou, Ning, et al.
Publicado: (2022)

Outcomes of lobectomy on pulmonary function for early stage non‐small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD)
por: Wei, Sen, et al.
Publicado: (2020)

Effect of Upper Arm Position Changes on the Occurrence of Ipsilateral Shoulder Pain After Single-Operator Port Thoracoscopy
por: Ren, Dian, et al.
Publicado: (2022)

Mediastinal lymph node dissection versus spared mediastinal lymph node dissection in stage IA non-small cell lung cancer presented as ground glass nodules: study protocol of a phase III, randomised, multicentre trial (MELDSIG) in China
por: Li, Chenguang, et al.
Publicado: (2023)

Circadian function in patients with advanced non-small-cell lung cancer
por: Levin, R D, et al.
Publicado: (2005)

Role of artemin in non‐small cell lung cancer
por: Song, Zuoqing, et al.
Publicado: (2018)

Characteristics of the immune microenvironment and their clinical significance in non-small cell lung cancer patients with ALK-rearranged mutation
por: Zhang, Bo, et al.
Publicado: (2022)

Use of savolitinib as neoadjuvant therapy for non–small cell lung cancer patient with MET exon 14 skipping alterations: A case report
por: Zhang, Yu, et al.
Publicado: (2022)

RAD51AP1在肿瘤进展和耐药中的研究进展
por: LIU, Renwang, et al.
Publicado: (2023)

Systematic pan-cancer analysis showed that RAD51AP1 was associated with immune microenvironment, tumor stemness, and prognosis
por: Liu, Renwang, et al.
Publicado: (2022)

Preliminary recommendations for lung surgery during COVID‐19 epidemic period
por: Li, Xin, et al.
Publicado: (2020)

Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement
por: Zhou, Ning, et al.
Publicado: (2022)

Salvage treatment with apatinib for advanced non-small-cell lung cancer
por: Song, Zhengbo, et al.
Publicado: (2017)

Circadian rhythm-associated clinical relevance and Tumor Microenvironment of Non-small Cell Lung Cancer
por: Li, Ming, et al.
Publicado: (2021)

Association of heartbeat complexity with survival in advanced non-small cell lung cancer patients
por: Wu, Shuang, et al.
Publicado: (2023)

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases
por: Li, Xin, et al.
Publicado: (2022)

Targeted therapies for advanced non-small cell lung cancer
por: Ai, Xiaojuan, et al.
Publicado: (2018)

Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis
por: Liu, Wenjie, et al.
Publicado: (2022)

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Xiong, Qi, et al.
Publicado: (2021)

Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
por: Wang, Yimin, et al.
Publicado: (2022)

Prognostic implication of glycolysis related gene signature in non-small cell lung cancer
por: Yao, Jie, et al.
Publicado: (2021)

Establishment of a prospective multicenter cohort for advanced non‐small cell lung cancer in China (CAPTRA‐Lung study)
por: Xu, Yan, et al.
Publicado: (2018)

Salvage treatment with anlotinib for advanced non‐small cell lung cancer
por: Wu, Di, et al.
Publicado: (2019)

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer
por: Xiang, Yan, et al.
Publicado: (2022)

A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer
por: Huo, LanQing, et al.
Publicado: (2023)

Recent advances in the treatment of non-small cell and small cell lung cancer
por: Stinchcombe, Thomas E.
Publicado: (2014)

PD-L1 expression is associated with advanced non-small cell lung cancer
por: Chen, Zhiquan, et al.
Publicado: (2016)

Emerging therapeutic agents for advanced non-small cell lung cancer
por: Chen, Ruqin, et al.
Publicado: (2020)

Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy
por: Li, Kuo, et al.
Publicado: (2021)

Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients
por: Gao, Ying, et al.
Publicado: (2015)

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer
por: Xu, Ruilian, et al.
Publicado: (2018)

Toripalimab plus chemotherapy vs. chemotherapy in patients with advanced non-small-cell lung cancer: A cost-effectiveness analysis
por: Huo, Gengwei, et al.
Publicado: (2023)

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
por: Huo, Geng-wei, et al.
Publicado: (2021)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer
por: Zhang, Xuening, et al.
Publicado: (2021)

Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
por: Ge, Xiangwei, et al.
Publicado: (2020)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Recent advances in the management of non-small cell lung cancer
por: Shojaee, Samira, et al.
Publicado: (2017)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kokr8h283r33nju7trlmilrr5r